Quick Answer
Edwards Lifesciences Corp reported Research And Development Expense of $1.08 billion for the year ending 2025.
- Edwards Lifesciences Corp showed an increase of +2.5% in Research And Development Expense from 2024 to 2025.
- This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), Edwards Lifesciences Corp's Research And Development Expense has grown by 675.3%.
- Historical annual values: Fiscal year 2025: $1.08 billion | Fiscal year 2024: $1.05 billion | Fiscal year 2023: $962.90 million | Fiscal year 2022: $843.60 million | Fiscal year 2021: $903.10 million | Fiscal year 2020: $760.70 million | Fiscal year 2019: $752.70 million | Fiscal year 2018: $622.20 million | Fiscal year 2017: $552.60 million | Fiscal year 2016: $442.20 million | Fiscal year 2015: $382.90 million | Fiscal year 2014: $346.50 million | Fiscal year 2013: $323.00 million | Fiscal year 2012: $291.30 million | Fiscal year 2011: $246.30 million | Fiscal year 2010: $204.40 million | Fiscal year 2009: $175.50 million | Fiscal year 2008: $139.20 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: